精准靶向迷走抗炎通路减轻烧伤后全身炎症反应
该研究在C57BL/6小鼠30%体表面积蒸汽烧伤模型上,于伤后30分钟腹腔注射α7nAchR选择性激动剂AR-R17779,检测伤后多个时间点肠道对4 kDa FITC-葡聚糖的通透性、伤后6小时肺血管通透性及系列行为学活动水平。结果显示肠通透性在伤后6小时达峰,AR-R17779剂量依赖性降低烧伤所致肠通透性(p < 0.001),5 mg/kg组肠通透性与假伤组无差异;烧伤使肺通透性升高10倍,AR-R17779阻止了该升高,与假伤组无差异(p < 0.01);治疗组烧伤动物伤后活动水平显著改善。作者认为直接刺激α7nAchR可预防烧伤所致肠肺损伤,直接靶向介导胆碱能抗炎反应的α7nAChR可能是优于非特异性迷走激动剂的策略。
要点
- C57BL/6小鼠30%体表面积蒸汽烧伤后30分钟腹腔注射α7nAchR选择性激动剂AR-R17779。
- AR-R17779剂量依赖性降低烧伤所致肠通透性(p < 0.001),5 mg/kg组肠通透性与假伤组无差异。
- 烧伤使肺通透性升高10倍,AR-R17779阻止该升高,与假伤组无差异(p < 0.01)。
- AR-R17779治疗组烧伤动物伤后活动水平显著改善。
- 作者认为直接靶向α7nAChR可能优于非特异性迷走激动剂策略。
适用人群与场景
- C57BL/6小鼠,30%体表面积蒸汽烧伤模型;为动物实验,非人类急诊或ICU人群。
处置流程与药物剂量
- 伤后30分钟腹腔注射α7nAchR选择性激动剂AR-R17779;5 mg/kg组肠通透性与假伤组无差异;剂量依赖性降低肠通透性(p < 0.001)。
研究设计与关键结果
- 研究类型:动物实验(C57BL/6小鼠30%体表面积蒸汽烧伤);干预:伤后30分钟腹腔注射AR-R17779;对照:假伤与烧伤未治疗。
- 肠通透性于伤后6小时达峰;AR-R17779剂量依赖性降低烧伤所致肠通透性(p < 0.001);5 mg/kg组肠通透性与假伤组无差异。
- 烧伤使肺通透性升高10倍,AR-R17779阻止该升高,与假伤组无差异(p < 0.01)。
- AR-R17779治疗组烧伤动物伤后活动水平显著改善。
证据类型、等级与局限
- 证据类型:动物实验(小鼠烧伤模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为直接刺激α7nAchR可预防烧伤所致肠肺损伤,直接靶向介导胆碱能抗炎反应的α7nAChR可能是优于非特异性迷走激动剂的策略;原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The systemic inflammatory response (SIRS) drives late morbidity and mortality after injury. The α7 nicotinic acetylcholine receptor (α7nAchR) expressed on immune cells regulates the vagal anti-inflammatory pathway that prevents an overwhelming SIRS response to injury. Nonspecific pharmacologic stimulation of the vagus nerve has been evaluated as a potential therapeutic to limit SIRS. Unfortunately, the results of clinical trials have been underwhelming. We hypothesized that directly targeting the α7nAchR would more precisely stimulate the vagal anti-inflammatory pathway on immune cells and decrease gut and lung injury after severe burn.
METHODS: C57BL/6 mice underwent 30% total body surface area steam burn. Mice were treated with an intraperitoneal injection of a selective agonist of the α7nAchR (AR-R17779) at 30 minutes postburn. Intestinal permeability to 4 kDa FITC-dextran was measured at multiple time points postinjury. Lung vascular permeability was measured 6 hours after burn injury. Serial behavioral assessments were performed to quantify activity levels.
RESULTS: Intestinal permeability peaked at 6 hours postburn. AR-R17779 decreased burn-induced intestinal permeability in a dose-dependent fashion (p < 0.001). There was no difference in gut permeability to 4 kDa FITC-dextran between sham and burn-injured animals treated with 5 mg/kg of AR-R17779. While burn injury increased lung permeability 10-fold, AR-R17779 prevented burn-induced lung permeability with no difference compared with sham (p < 0.01). Postinjury activity levels were significantly improved in burned animals treated with AR-R17779.
CONCLUSION: Directly stimulating the α7nAchR prevents burn-induced gut and lung injury. Directly targeting the α7nAChR that mediates the cholinergic anti-inflammatory response may be an improved strategy compared with nonspecific vagal agonists.
参考来源
- Costantini TW, Coimbra R, Weaver JL, et al. Precision targeting of the vagal anti-inflammatory pathway attenuates the systemic inflammatory response to burn injury. J Trauma Acute Care Surg. 2022. PMID: 34789702. doi:10.1097/TA.0000000000003470
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。